Skip to main content

Biopharma Startups

Updated November 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 915 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
915
Total Funding
$1.1B
Avg Funding
$44.9M
Global Reach
8
countries

Top Cities for Biopharma

Boston
Recoleta
Palo Alto
Budapest
Cambridge
Seattle

Recently Funded Companies

Export
Boston, United States

Precede Biosciences is a biotechnology company that provides a blood-based approach to reveal disease-defining transcriptional biology.

$63.5M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Recoleta, Argentina

BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment.

$8.0M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Palo Alto, United States

Juvena Therapeutics develops tissue-restorative biologics to address chronic muscle and age-related conditions.

$33.5M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Budapest, Hungary

Novamigra Therapeutics is a biotechnology research organisation engaged in advancing a novel approach to migraine prophylaxis.

$3.5M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,

$50.0M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Seattle, United States

Designing innovative technologies focused on accelerating global access to biotherapeutics.

Jan 2026

Founder Contacts

41,000+ verified contacts

Milano, Italy

Bio-tech company producing functional and bioactive ingredients

$117K raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Watertown, United States

Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.

$125.0M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark

Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.

$1.0M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Toulouse, France

SWEETECH is a deeptech startup developed a patented platform for environmentally friendly production of oligosaccharides via fermentation.

$2.6M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

San Diego, United States

Biotechnology company developing pharmaceutical therapies for nerve regeneration in the central nervous system.

$2.5M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

LIFE AI is an AI-powered blockchain platform for decentralized science in genomics, enabling users to own, control, monetize personal data.

Jan 2026

Founder Contacts

41,000+ verified contacts

New York, United States

Intelligent Bio Solutions leverages the power of technology to develop transformative, accurate solutions that improve quality of life.

$10.0M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Seattle, United States

Digital Biotechnologies is a biotechnology company.

$12.3M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Bellevue, United States

Mitera Biosciences is a biotech innovator using non-invasive skin epigenetics to advance anti-aging insights.

$1.8M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

San Carlos, United States

Sift Biosciences is a biotechnology research company that offers cancer therapies.

$3.8M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Mantis biotech builds a unified biomedical device testing and regulatory platform

$275K raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Cambridge, United States

CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.

$30.0M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Utrecht, The Netherlands

TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.

$25.3M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.

$55.0M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Baar, Switzerland

Swixx Biopharma fully represents biopharma companies in the CEE.

Dec 2025

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.

$60.0M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

New York, United States

Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases.

$550.0M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

San Diego, United States

Illudent is a biotechnology company that offers precision medicine treatment for cancer patients.

$250K raised
Dec 2025

Founder Contacts

41,000+ verified contacts

San Diego, United States

BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.

$84.0M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Showing 226 to 250 of 915 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 915 biopharma companies tracked in the VCBacked database.

Average Funding
$44.9M
Total Funding Tracked
$1.1B
Countries Represented
8

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.San Francisco
4 companies$115.3M
2.San Diego
3 companies$86.8M
3.Cambridge
2 companies$80.0M
4.Seattle
2 companies$12.3M
5.New York
2 companies$560.0M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked